Author:
Buccisano Francesco,Hourigan Christopher S.,Walter Roland B.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Reference88 articles.
1. Bisel HF. Letter to the editor: criteria for the evaluation of response to treatment in acute leukemia. Blood. 1956;11(7):676–7.
2. • Hourigan CS, Gale RP, Gormley NJ, Ossenkoppele GJ, Walter RB. Measurable residual disease testing in acute myeloid leukaemia. Leukemia. 2017;31(7):1482–90. Comprehensive review on MRD-testing in AML.
3. Hagenbeek A, ACM M. Kinetics of minimal residual disease in a rat model for human acute myelocytic leukemia. In: Baum SJ, Ledney GD, van Bekkum DW, editors. Experimental hematology today. New York: Springer; 1980. p. 215–21.
4. Buccisano F, Maurillo L, Del Principe MI, Del Poeta G, Sconocchia G, Lo-Coco F, et al. Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. Blood. 2012;119(2):332–41.
5. •• Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–47. State-of-the art guidelines on diagnosis and management of adult patients with AML, written by international group of experts.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献